ServiceNow Business Continuity Management for Life Sciences and Pharma

Manufacturing Continuity

Life sciences and pharmaceutical organizations often operate manufacturing facilities with tight production schedules and high capital equipment costs. Business continuity planning protects manufacturing capacity from disruptions: equipment failures, facility damage, or supply shortages.

Business continuity strategies include: preventive maintenance reducing equipment failures, spare equipment for critical operations, backup manufacturing sites, and surge production capacity before anticipated disruptions. When disruptions occur, continuity plans guide response: which functions shift to backup sites, what increased staffing is needed, and how customer communication is managed.

Supply Chain Resilience

Pharmaceutical manufacturing depends on reliable supply chains: active pharmaceutical ingredients, excipients, packaging materials, and specialized chemicals. Single-source suppliers create vulnerability: if one supplier faces disruption, production stops. Continuity planning identifies critical suppliers, diversifies sources where possible, and maintains strategic inventory of critical materials.

Supply chain planning also accounts for regulatory requirements: suppliers must be approved and validated. Adding a new supplier takes time. Advance planning and supplier qualification support rapid supplier switching if primary suppliers fail.

Regulatory Compliance During Disruptions

Pharmaceutical manufacturing continues operating under regulatory requirements even during disruptions. If manufacturing shifts to a backup site, that site must be validated and approved for manufacturing. If production timelines are disrupted, regulatory notifications may be required.

Continuity planning coordinates with regulatory affairs teams to ensure that continuity actions comply with regulatory requirements and that any regulatory notifications are prepared promptly.

Data and System Resilience

Manufacturing systems, research databases, and regulatory documentation are critical to operations. System failures could disrupt manufacturing or prevent compliance documentation. Backup systems, redundant storage, and disaster recovery plans protect critical data.

Personnel and Skills

Specialized manufacturing processes require trained personnel. Cross-training ensures that if key personnel become unavailable, others can perform critical tasks. Continuity planning identifies critical roles and ensures backup personnel are trained and ready.

Supply Chain Mapping

Understand dependencies: which products depend on which suppliers, which manufacturing sites supply which products, and which distribution channels serve which customers. Mapping these relationships helps identify risks and single points of failure.

Stakeholder Communication

When disruptions occur, customers, regulators, and other stakeholders must be notified promptly. Continuity plans should include communication procedures and templates for different types of disruptions.

Common Challenges

Cost versus resilience trade-offs: backup capacity and redundant suppliers cost money. Leadership must balance resilience investment against other business priorities.

Long lead times: replacing failed equipment or adding new suppliers often requires months. Advance planning and inventory buffer are necessary to bridge long lead times.

Regulatory changes: regulations affecting where manufacturing can be performed or what suppliers are acceptable may change. Continuity plans must be flexible enough to adapt to regulatory changes.

Risk Assessment and Contingency Planning

Identify which vendors, suppliers, or manufacturing sites are most critical. Assess what happens if each becomes unavailable: how long can operations continue, what impact on customers, what recovery costs. Use risk assessment to prioritize continuity planning efforts: invest most heavily in protection of highest-risk dependencies.

Communication and Coordination During Disruptions

Communication plans should define how the organization communicates with customers, regulators, employees, and other stakeholders during disruptions. Communication should be frequent, accurate, and transparent. Regular updates help prevent speculation and rumors. Clear communication about actions being taken and expected recovery timelines helps manage stakeholder anxiety.

Continuity Testing and Validation

Business continuity plans must be tested regularly. Table-top exercises: personnel review scenarios and discuss how they would respond. Simulation exercises: actually execute portions of continuity plans to verify they work. Recovery time objective (RTO) and recovery point objective (RPO) targets help assess whether plans will meet operational needs when actually needed. Testing should be documented, and lessons learned should inform plan improvements. Annual testing is a minimum for most organizations; more frequent testing for critical functions is recommended.

Turning a business impact analysis into continuity decisions for a plant

A continuity plan for a manufacturing site is only as good as the impact analysis underneath it. Start with duration rather than with hazards: how long can each product line stop before the loss becomes unrecoverable? The business continuity management record should hold those answers so every later decision points back to them. For some sterile or biologic products the answer is measured in days and the cost of a missed supply window is far larger than the cost of a spare part. For others, a stoppage of several weeks is an inconvenience. Those answers set the recovery targets, and the recovery targets then decide which strategies are worth paying for.

Procedure for running the impact analysis

1. List each product line and the equipment, utilities, systems and suppliers it needs to run, using the production records rather than the org chart.
2. For each dependency, estimate the time to restore it and the time to resume output once it is back, since the second is often the longer of the two.
3. Set a maximum tolerable downtime per product line, agreed by the site head and the quality head together, and record who signed it.
4. Compare each dependency’s restoration time with that limit. Any gap is a candidate for a strategy, and gaps that cannot be closed go to the risk register.
5. Choose strategies for the gaps, estimate what each costs in capital, inventory and validation work, and get the decision approved at the level that owns the risk.
6. Write the plan around the decisions, not around the departments, so each action has a trigger, an owner and a validation status.

What the plan has to record that generic templates leave out

A plan that says move production to the second site has not finished its work. The service side of the same question is covered by the availability and service continuity service. It needs to say which product codes may move, which equipment at the second site is qualified for them, which regulatory notifications apply to a change of manufacturing location, and who authorizes the first batch there. Those are the points where a continuity event becomes a compliance event. Record them as explicit decision points with their evidence attached, so the person on duty is not reconstructing them under pressure.

Linking the plan to the CMDB so impact is visible

Dependency lists drawn up in a workshop can go stale quickly. The configuration management database is a common home for these relationships. Where it holds the relationships between equipment, utilities, applications and products, the analysis can start from what is recorded and show which products sit behind a failing chiller or a single integration. The impact method is set out in this note on service impact analysis. The catch is that relationships must be maintained. A relationship that was never recorded may not appear in the impact view, and the plan will look more complete than it is. Reconcile the recorded dependencies against the site walk-down at least as often as the plan is tested.

Exercises that expose the gaps a plan hides

• A tabletop run that starts with a loss of utilities at night, so the test covers who can be reached and how long it takes them to arrive.
• A partial live check of the backup equipment, confirming that it starts, reads correctly and produces the same outputs in the test record.
• A communications drill that sends the holding statement to customers and regulatory contacts, to check contact details and approval routes.
• A restore test for the data that the continuity plan assumes will be available, because a recovered line with missing batch history may be unable to release product.

When a full continuity plan is premature

A site that has not yet agreed its product priorities, or whose equipment register is incomplete, can produce a plan that has to be rewritten within months. In that situation the more useful first step is the impact analysis alone, approved and kept current, with the strategy work scheduled behind it. A plan written before the analysis can protect the wrong things.

Questions about continuity planning in regulated manufacturing

Does a backup site need to be inspected before it can take over production?

Where the site is not already approved for the product, yes, and that often means regulatory approval of the site change as well as internal qualification. Confirm the position with regulatory affairs when the strategy is chosen, not during the event.

How should a plan treat a single critical supplier?

Map the supplier’s own continuity position where the contract allows it, hold safety stock sized to the recovery target, and pre-qualify a second source where the approval process will take longest. The supplier risk belongs in the same register as the equipment risk.

Who should be on the activation list?

Name roles rather than individuals, then attach the people currently holding each role. The list should include the person who can authorize a change in manufacturing location, because that decision is often the bottleneck.

How often should the impact analysis be reviewed?

Review it when a product line, a major piece of equipment or a supplier changes, and on the schedule the quality system already uses for periodic reviews. An analysis that has not changed in a long time is more likely to be out of date than correct.